Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Ease of Use of Norditropin NordiFlex® Relative to the One of the Device Previously Used by Patients or Parents

NCT01245374 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01245374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01245374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Ease of Use of Norditropin NordiFlex® Relative to the One of the Device Previously Used by Patients or Parents
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2010
Completion date
April 30, 2011
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, chronic renal insufficiency, delivery systems, foetal growth problem, genetic disorder, growth hormone deficiency in children, growth hormone disorder, small for gestational age, turner syndrome